RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2007; 97(04): 503-504
DOI: 10.1160/TH07-03-0176
DOI: 10.1160/TH07-03-0176
Editorial Focus
Hormonal therapy with patch or pill: How much does it matter?
Autoren
Weitere Informationen
Publikationsverlauf
Received
06. März 2007
Accepted
06. März 2007
Publikationsdatum:
24. November 2017 (online)
-
References
- 1 Jick H, Derby LE, Myers MW. et al. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1996; 348: 981-983.
- 2 Grodstein F, Stampfer M J, Goldhaber S Z. et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996; 348: 983-987.
- 3 Daly E, Vessey MP, Hawkins MM. et al. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348: 977-980.
- 4 Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. J Am Med Assoc 2002; 288: 321-333.
- 5 The WHI steering committee. Effects of conjugated equine estrogens in postmenopausal women with hysterectomy. J Am Med Assoc 2004; 291: 1701-1712.
- 6 Herkert O, Kuhl H, Sandow J. et al. Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor. Circulation 2001; 104: 2826-2831.
- 7 Scarabin P-Y, Oger E, Plu-Bureau G. for the ESTHER study group. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 2003; 362: 428-432.
- 8 Canonico M, Straczek C, Oger E. et al. Postmenopausal hormone therapy and cardiovascular disease: an overview of main findings. Maturitas 2006; 54: 372-379.
- 9 Straczek C, Oger E, Yon de Jonage-Canonico MB. et al. Estrogen and Thromboembolism Risk (ESTHER) Study Group. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration. Circulation 2005; 112: 3495-3500.
- 10 Wu O. Postmenopausal hormone replacement therapy and venous thromboembolism. Gend Med 2005; 2: S18-27. Suppl A
- 11 Brosnan JF, Sheppard BL, Norris LA. Haemostatic activation in post menopausal women taking low dose hormone therapy: Less effect with transdermal administration?. Thromb Haemost 2007; 97: 558-565.